On the last conference call, GC mentioned that the
Post# of 30026
Posted On: 03/03/2016 1:13:39 PM
On the last conference call, GC mentioned that the Phase 2b trial for Eltoprazine was paused.
Then he said that they are trying to modify the trial design from a Phase 2b to a Phase 2/3 pivotal design.
"PIVOTAL STUDY: A study, usually Phase 3, which presents the data used by regulatory agencies to decide whether to approve a drug."
That sounds good to me.
Then he said that they are trying to modify the trial design from a Phase 2b to a Phase 2/3 pivotal design.
"PIVOTAL STUDY: A study, usually Phase 3, which presents the data used by regulatory agencies to decide whether to approve a drug."
That sounds good to me.
(5)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼